BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25059326)

  • 1. Evaluating protein-protein interaction (PPI) networks for diseases pathway, target discovery, and drug-design using 'in silico pharmacology'.
    Chakraborty C; Doss C GP; Chen L; Zhu H
    Curr Protein Pept Sci; 2014; 15(6):561-71. PubMed ID: 25059326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network analysis and in silico prediction of protein-protein interactions with applications in drug discovery.
    Murakami Y; Tripathi LP; Prathipati P; Mizuguchi K
    Curr Opin Struct Biol; 2017 Jun; 44():134-142. PubMed ID: 28364585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
    Shin WH; Christoffer CW; Kihara D
    Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovering Innovative Drugs Targeting Both Cancer and Cardiovascular Disease by Shared Protein-Protein Interaction Network Analyses.
    Tiwari S; Dwivedi UN
    OMICS; 2019 Sep; 23(9):417-425. PubMed ID: 31329050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein-Protein Interaction Interfaces.
    Rooklin D; Wang C; Katigbak J; Arora PS; Zhang Y
    J Chem Inf Model; 2015 Aug; 55(8):1585-99. PubMed ID: 26225450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico Enhancing M. tuberculosis Protein Interaction Networks in STRING To Predict Drug-Resistance Pathways and Pharmacological Risks.
    Mei S
    J Proteome Res; 2018 May; 17(5):1749-1760. PubMed ID: 29611419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-Protein Interaction (PPI) Network: Recent Advances in Drug Discovery.
    Athanasios A; Charalampos V; Vasileios T; Ashraf GM
    Curr Drug Metab; 2017; 18(1):5-10. PubMed ID: 28889796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-protein interactions: network analysis and applications in drug discovery.
    Bultinck J; Lievens S; Tavernier J
    Curr Pharm Des; 2012; 18(30):4619-29. PubMed ID: 22650261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational modulator design by exploitation of protein-protein complex structures.
    Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
    Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SiPAN: simultaneous prediction and alignment of protein-protein interaction networks.
    Alkan F; Erten C
    Bioinformatics; 2015 Jul; 31(14):2356-63. PubMed ID: 25788620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the relationship between hub proteins and drug targets based on GO and intrinsic disorder.
    Fu Y; Guo Y; Wang Y; Luo J; Pu X; Li M; Zhang Z
    Comput Biol Chem; 2015 Jun; 56():41-8. PubMed ID: 25854804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational probing protein-protein interactions targeting small molecules.
    Wang YC; Chen SL; Deng NY; Wang Y
    Bioinformatics; 2016 Jan; 32(2):226-34. PubMed ID: 26415726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemical libraries dedicated to protein-protein interactions].
    Sperandio O; Villoutreix BO; Morelli X; Roche P
    Med Sci (Paris); 2015 Mar; 31(3):312-9. PubMed ID: 25855285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of protein-protein interaction networks based on binding affinity.
    Yugandhar K; Gromiha MM
    Curr Protein Pept Sci; 2016; 17(1):72-81. PubMed ID: 26412787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale analysis of disease pathways in the human interactome.
    Agrawal M; Zitnik M; Leskovec J
    Pac Symp Biocomput; 2018; 23():111-122. PubMed ID: 29218874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network analysis and cross species comparison of protein-protein interaction networks of human, mouse and rat cytochrome P450 proteins that degrade xenobiotics.
    Karthikeyan BS; Akbarsha MA; Parthasarathy S
    Mol Biosyst; 2016 Jun; 12(7):2119-34. PubMed ID: 27194593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural systems pharmacology: the role of 3D structures in next-generation drug development.
    Duran-Frigola M; Mosca R; Aloy P
    Chem Biol; 2013 May; 20(5):674-84. PubMed ID: 23706634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-based strategies can help mono- and poly-pharmacology drug discovery: a systems biology view.
    Engin HB; Gursoy A; Nussinov R; Keskin O
    Curr Pharm Des; 2014; 20(8):1201-7. PubMed ID: 23713773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature.
    Poornima P; Kumar JD; Zhao Q; Blunder M; Efferth T
    Pharmacol Res; 2016 Sep; 111():290-302. PubMed ID: 27329331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distance-wise pathway discovery from protein-protein interaction networks weighted by semantic similarity.
    Jaromerska S; Praus P; Cho YR
    J Bioinform Comput Biol; 2014 Feb; 12(1):1450004. PubMed ID: 24467762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.